Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 2 (2005), Issue 1 (January)

1. Cutaneous papillomatosis in cattle.
   J Comp Pathol, 132(1): 70-81. [Abstract] [Full-text]
2. Eyelid tumour and juvenile hyaline fibromatosis.
   Br J Plast Surg, 58(1): 106-11. [Abstract] [Full-text]
3. Late recurrence of dermatofibrosarcoma protuberans in the female breast: a case report.
   Br J Plast Surg, 58(1): 84-7. [Abstract] [Full-text]
4. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin.
   Mod Pathol, 18(1): 137-42. [Abstract] [Full-text]
5. Early TCR-beta and TCR-gamma PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications.
   Blood, 105(2): 503-10. [Abstract] [Full-text]
6. Eccrine hidrocystoma of the eyelid.
   Eye, 19(1): 77-9. [Abstract] [Full-text]
7. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
   Gene Ther, 12(2): 140-6. [Abstract] [Full-text]
8. Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction.
   Gene Ther, 12(2): 129-39. [Abstract] [Full-text]
9. Current management of hemangiomas and vascular malformations.
   Clin Plast Surg, 32(1): 99-116, ix. [Abstract] [Full-text]
10. Treatment of large and giant nevi.
    Clin Plast Surg, 32(1): 11-8, vii. [Abstract] [Full-text]
11. Concomitant pilomatrixoma and peripheral schwannoma in a child.
    Klin Padiatr, 217(1): 34-5. [Abstract] [Full-text]
12. Asiatic acid induces apoptosis in SK-MEL-2 human melanoma cells.
    Cancer Lett, 218(1): 81-90. [Abstract] [Full-text]
13. Polysaccharides isolated from Phellinus gilvus inhibit melanoma growth in mice.
    Cancer Lett, 218(1): 43-52. [Abstract] [Full-text]
14. Major amputation for intractable extremity melanoma after failure of isolated limb perfusion.
    Eur J Surg Oncol, 31(1): 95-9. [Abstract] [Full-text]
15. Extra nodal growth as a prognostic factor in malignant melanoma.
    Eur J Surg Oncol, 31(1): 88-94. [Abstract] [Full-text]
16. Polyamines modulate carcinogen-induced mutagenesis in vivo.
    Environ Mol Mutagen, 45(1): 62-9. [Abstract] [Full-text]
17. Interaction between the immune system and tumor cells: cutaneous disorders as a consequence of autoimmunity and immunosuppression.
    Ann N Y Acad Sci, 1028: 375-9. [Abstract] [Full-text]
18. Giant nevus lipomatosus superficialis with multiple folliculosebaceous cystic hamartomas and dermoid cysts.
    J Eur Acad Dermatol Venereol, 19(1): 84-6. [Abstract] [Full-text]
19. Evaluation of extensive initial staging procedure in intermediate/high-risk melanoma patients.
    J Eur Acad Dermatol Venereol, 19(1): 66-73. [Abstract] [Full-text]
20. Decreased expression of Apaf-1 with progression of melanoma.
    Pigment Cell Res, 18(1): 59-62. [Abstract] [Full-text]
21. MAGE-A3 is a frequent tumor antigen of metastasized melanoma.
    Arch Dermatol Res, 296(7): 314-9. [Abstract] [Full-text]
22. Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma.
    Cancer Immunol Immunother, 54(3): 208-18. [Abstract] [Full-text]
23. Colonization of adjacent stem cell compartments by mutant keratinocytes.
    Semin Cancer Biol, 15(2): 97-102. [Abstract] [Full-text]
24. Tissue homeostasis and the control of the neoplastic phenotype in epithelial cancers.
    Semin Cancer Biol, 15(2): 75-83. [Abstract] [Full-text]
25. Resection of skin metastases from gastric carcinoma with long-term follow-up: an unusual clinical presentation.
    Onkologie, 28(1): 38-40. [Abstract] [Full-text]
26. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma.
    Cancer, 103(2): 417-21. [Abstract] [Full-text]
27. Small bowel intussusception due to metastatic malignant melanoma. A case report.
    Tech Coloproctol, 8: s141-3. [Abstract] [Full-text]
28. Identifying risk factors for complications following sentinel lymph node biopsy for melanoma.
    Arch Surg, 140(1): 85-9. [Abstract] [Full-text]
29. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy.
    Arch Dermatol, 141(1): 60-7. [Abstract] [Full-text]
30. Shape discrimination by total curvature, with a view to cancer diagnostics.
    J Microsc, 217: 49-59. [Abstract] [Full-text]
31. Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1+/- mice.
    J Invest Dermatol, 124(1): 263-7. [Abstract] [Full-text]
32. Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression.
    J Invest Dermatol, 124(1): 221-8. [Abstract] [Full-text]
33. Epitope-specific antibody response to Mel-CAM induced by mimotope immunization.
    J Invest Dermatol, 124(1): 125-31. [Abstract] [Full-text]
34. Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib.
    Eur J Haematol, 74(2): 121-3. [Abstract] [Full-text]
35. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle.
    Genes Dev, 19(2): 214-23. [Abstract] [Full-text]
36. Bowen's disease on the sole: p16INK4a overexpression associated with human papillomavirus type 16.
    Br J Dermatol, 152(1): 170-3. [Abstract] [Full-text]
37. Detection of 1733insC mutations in an Asian family with Birt-Hogg-Dubé syndrome.
    Br J Dermatol, 152(1): 142-5. [Abstract] [Full-text]
38. Thick melanoma: the challenge persists.
    Br J Dermatol, 152(1): 104-9. [Abstract] [Full-text]
39. Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy.
    Br J Dermatol, 152(1): 87-92. [Abstract] [Full-text]
40. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients.
    Br J Dermatol, 152(1): 66-70. [Abstract] [Full-text]
41. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
    Br J Dermatol, 152(1): 43-51. [Abstract] [Full-text]
42. Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathways.
    Cancer Gene Ther, 12(2): 162-74. [Abstract] [Full-text]
43. Prognostic implications of multiple lymphatic basin drainage in patients with truncal melanoma.
    J Clin Oncol, 23(3): 518-24. [Abstract] [Full-text]
44. Acitretin and skin cancer in kidney transplanted patients. Clinical and histological evaluation and immunohistochemical analysis of lymphocytes, natural killer cells and Langerhans' cells in sun exposed and sun protected skin.
    Clin Transplant, 19(1): 115-21. [Abstract] [Full-text]
45. Treatment of multiple trichoepitheliomas with topical imiquimod and tretinoin.
    Pediatr Dermatol, 22(1): 67-70. [Abstract] [Full-text]
46. Epidermal nevus syndrome associated with adnexal tumors, spitz nevus, and hypophosphatemic vitamin D-resistant rickets.
    Pediatr Dermatol, 22(1): 48-54. [Abstract] [Full-text]
47. Phacomatosis pigmentokeratotica: a 20-year follow-up with malignant degeneration of both nevus components.
    Pediatr Dermatol, 22(1): 44-7. [Abstract] [Full-text]
48. Concurrent mycosis fungoides and precursor B cell lymphoblastic lymphoma in a 6-year-old child.
    Pediatr Dermatol, 22(1): 23-5. [Abstract] [Full-text]
49. Cutaneous tumors as the initial presentation of non-T, non-B, nonmyeloid CD4+ CD56+ hematolymphoid malignancy in an adolescent boy.
    Pediatr Dermatol, 22(1): 19-22. [Abstract] [Full-text]
50. Autopsy case of CD4/CD8 cutaneous T-cell lymphoma presenting disseminated pagetoid reticulosis with aggressive granulomatous invasion to the lungs and pancreas.
    Pathol Int, 55(1): 32-9. [Abstract] [Full-text]
51. Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi.
    J Cutan Pathol, 32(1): 45-9. [Abstract] [Full-text]
52. Congenital panfollicular nevus: report of a new entity.
    J Cutan Pathol, 32(1): 59-62. [Abstract] [Full-text]
53. Cyclooxygenase-2 expression in primary Merkel cell carcinoma.
    J Cutan Pathol, 32(1): 55-8. [Abstract] [Full-text]
54. Cluster designation 5 staining of normal and non-lymphoid neoplastic skin.
    J Cutan Pathol, 32(1): 50-4. [Abstract] [Full-text]
55. The characteristic histopathologic features of nevi on and around the ear.
    J Cutan Pathol, 32(1): 40-4. [Abstract] [Full-text]
56. Epstein-Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation.
    J Cutan Pathol, 32(1): 35-9. [Abstract] [Full-text]
57. HHV-8/KSHV during the development of Kaposi's sarcoma: evaluation by polymerase chain reaction and immunohistochemistry.
    J Cutan Pathol, 32(1): 21-7. [Abstract] [Full-text]
58. The application of a monoclonal antibody to CD62L on paraffin-embedded tissue samples in the assessment of the cutaneous T-cell infiltrates.
    J Cutan Pathol, 32(1): 12-20. [Abstract] [Full-text]
59. Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis.
    J Cutan Pathol, 32(1): 2-11. [Abstract] [Full-text]
60. High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma.
    Cancer Biother Radiopharm, 19(6): 770-5. [Abstract] [Full-text]
61. Individualized synthetic peptide vaccines with GM-CSF in locally advanced melanoma patients.
    Cancer Biother Radiopharm, 19(6): 758-63. [Abstract] [Full-text]
62. Continuous infusion interleukin-2 and antihistamines in melanoma: a retrospective review showing activity of this combination.
    Cancer Biother Radiopharm, 19(6): 754-7. [Abstract] [Full-text]
63. Persistent Mongolian spots in Chinese adults.
    Int J Dermatol, 44(1): 43-5. [Abstract] [Full-text]
64. Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization.
    Int J Dermatol, 44(1): 25-8. [Abstract] [Full-text]
65. Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer.
    Clin Exp Dermatol, 30(1): 75-8. [Abstract] [Full-text]
66. Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome.
    Clin Exp Dermatol, 30(1): 68-70. [Abstract] [Full-text]
67. Basal cell carcinoma: from host response and polymorphic variants to tumour suppressor genes.
    Clin Exp Dermatol, 30(1): 49-55. [Abstract] [Full-text]
68. Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody.
    Clin Exp Dermatol, 30(1): 46-8. [Abstract] [Full-text]
69. Skin cancer chemopreventive agent, {alpha}-santalol, induces apoptotic death of human epidermoid carcinoma A431 cells via caspase activation together with dissipation of mitochondrial membrane potential and cytochrome c release.
    Carcinogenesis, 26(2): 369-80. [Abstract] [Full-text]
70. Powerful skin cancer protection by a CPD-photolyase transgene.
    Curr Biol, 15(2): 105-15. [Abstract] [Full-text]
71. Skin cancer: lights on genome lesions.
    Curr Biol, 15(2): R58-61. [Abstract] [Full-text]
72. Wavelet analysis of cutaneous blood flow in melanocytic skin lesions.
    J Vasc Res, 42(1): 38-46. [Abstract] [Full-text]
73. SEREX identification of new tumor antigens linked to melanoma-associated retinopathy.
    Int J Cancer, 114(1): 88-93. [Abstract] [Full-text]
74. No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma.
    Eur J Hum Genet, 13(2): 253-5. [Abstract] [Full-text]
75. Perianal apocrine adenocarcinoma arising in a benign apocrine adenoma; first case report and review of the literature.
    J Clin Pathol, 58(2): 217-9. [Abstract] [Full-text]
76. Eruptive tufted angiomas in a patient with Crohn's disease.
    J Clin Pathol, 58(2): 214-6. [Abstract] [Full-text]
77. Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome.
    Cancer Genet Cytogenet, 157(1): 1-11. [Abstract] [Full-text]
78. Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling.
    J Invest Dermatol, 124(2): 412-8. [Abstract] [Full-text]
79. Glycyrrhizin induces melanogenesis by elevating a cAMP level in b16 melanoma cells.
    J Invest Dermatol, 124(2): 405-11. [Abstract] [Full-text]
80. Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin).
    J Invest Dermatol, 124(2): 308-14. [Abstract] [Full-text]
81. Tumor-prone phenotype of the DDB2-deficient mice.
    Oncogene, 24(3): 469-78. [Abstract] [Full-text]
82. Ron tyrosine kinase receptor regulates papilloma growth and malignant conversion in a murine model of skin carcinogenesis.
    Oncogene, 24(3): 479-88. [Abstract] [Full-text]
83. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.
    J Clin Oncol, 23(4): 866-73. [Abstract] [Full-text]
84. Mortality risk from squamous cell skin cancer.
    J Clin Oncol, 23(4): 759-65. [Abstract] [Full-text]
85. High-throughput mitochondrial genome screening method for nonmelanoma skin cancer using multiplexed temperature gradient capillary electrophoresis.
    Clin Chem, 51(2): 305-11. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.